Simultaneous analysis for forensic drugs in human blood and urine using ultra-high speed LC-MS/MS

Significance of Topic

The rapid and reliable detection of drugs of abuse in biological fluids is a critical component of forensic toxicology and clinical diagnostics. Traditional workflows often involve time-consuming sample preparation and lengthy chromatographic runs. Leveraging ultra-high-speed liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS) and a simplified extraction protocol enables high-throughput screening while maintaining sensitivity and accuracy.

Study Objectives and Overview

This study describes the development and validation of a streamlined analytical platform for simultaneous quantification of 18 forensic-relevant compounds in human whole blood and urine. The key goals were to shorten total analysis time, achieve robust matrix cleanup via a modified QuEChERS approach, and demonstrate linearity, reproducibility, and adequate recovery across a wide concentration range.

Instrumental Setup

• UHPLC System: Shimadzu Nexera UHPLC configured for rapid gradient elution
• Column: YMC Triart C18, 100 × 2.0 mm, 1.9 μm particle size, operated at 40 °C
• Mass Spectrometer: Shimadzu LCMS-8050 triple quadrupole with heated electrospray ionization
• Acquisition Mode: Scheduled multiple reaction monitoring (MRM) for positive and negative polarities; synchronized survey scan for compound confirmation

Methodology and Sample Preparation

A modified QuEChERS protocol was applied to whole blood and urine samples:

• Aliquot 0.5 mL of sample and dilute with 1 mL water
• Add 1.5 mL acetonitrile spiked with deuterated internal standard (Diazepam-d5)
• Incorporate Q-sep™ extraction salts (MgSO₄ and NaOAc) plus stainless steel beads for agitation
• Vortex, centrifuge, and collect the organic layer; evaporate under nitrogen
• Reconstitute in methanol, centrifuge, and transfer to an HPLC vial

Chromatographic separation used a water/ammonium formate and methanol gradient at 0.3 mL/min over 20 minutes. MS parameters were optimized for each analyte to ensure low-level detection.

Main Results and Discussion

Calibration curves were established for 12 compounds in the 0.01–1 ng/mL range and for 6 compounds in the 1–100 ng/mL range. All analytes exhibited excellent linearity (R² > 0.997) in both blood and urine matrices. Signal-to-noise ratios at the lower limit of quantitation ranged from ~15 to >160, demonstrating high sensitivity. Recoveries were consistent across acidic, neutral, and basic drugs. Inter- and intra-day precision values were below 12% CV at the lowest spiking levels.

Benefits and Practical Applications

The combined approach offers:

• High throughput: sample preparation and analysis within 20 minutes per batch
• Sensitivity: detection limits suitable for forensic and clinical purposes
• Simplicity: single extraction protocol for diverse compounds
• Versatility: applicable to both blood and urine samples

This workflow supports routine toxicological screening in forensic laboratories, driving timely decision-making in legal and medical contexts.

Future Trends and Opportunities

Emerging directions include:

• Integration of automated, on-line sample preparation to reduce manual handling
• Expansion of target panels to cover novel psychoactive substances
• Adoption of high-resolution mass spectrometry for non-targeted screening
• Implementation of data processing pipelines driven by machine learning to accelerate compound identification

Conclusion

The validated method combining modified QuEChERS extraction with ultra-high-speed UHPLC-MS/MS achieves rapid, sensitive, and reproducible quantification of a broad spectrum of forensic drugs in human blood and urine. Its high throughput and straightforward workflow make it ideally suited for routine forensic toxicology and clinical screening applications.

Reference

Usui K, et al. Legal Medicine. 2012;14:286–296.